Standard BioTools Inc.
LAB
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpā¦ read more
Healthcare
Diagnostics & Research
14 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.13
Price+0.89%
$0.01
1Y
Price
Market Cap
$434.559m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-74.7%
EBITDA Margin-153.7%
Net Profit Margin-103.6%
Free Cash Flow MarginRevenue
$154.244m
-11.6%
1y CAGR+20.3%
3y CAGR+9.0%
5y CAGREarnings
-$120.502m
+13.2%
1y CAGR-4.0%
3y CAGR-58.2%
5y CAGREPS
-$0.32
+38.5%
1y CAGR+48.2%
3y CAGR-16.8%
5y CAGRBook Value
$424.535m
$556.965m
Assets$132.430m
Liabilities$28.616m
DebtDebt to Assets
5.1%
-0.3x
Debt to EBITDAFree Cash Flow
-$105.457m
+30.5%
1y CAGR-49.4%
3y CAGR-52.7%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company